Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (Q43950414)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol |
scientific article |
Statements
1 reference
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (English)
1 reference
Ulf de Faire
1 reference
Ole Lederballe-Pedersen
1 reference
Sverre E Kjeldsen
1 reference
Richard B Devereux
1 reference
Suzanne Oparil
1 reference
Lars H Lindholm
1 reference
Hans Ibsen
1 reference
Gareth Beevers
1 reference
Frej Fyhrquist
1 reference
Stevo Julius
1 reference
Krister Kristiansson
1 reference
Markku S Nieminen
1 reference
Per Omvik
1 reference
Hans Wedel
1 reference
Peter Aurup
1 reference
Jonathan Edelman
1 reference
Steven Snapinn
1 reference
LIFE Study Group
1 reference
1 March 2002
1 reference
1 reference
Identifiers
1 reference